Narcolepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been clearly diagnosed by a specialist with insomnia, narcolepsy, or RBD (a sleep disorder where people act out their dreams during sleep) and are willing to sign a consent form to participate.
Who may not be able to join:
- You have a major brain or nervous system condition such as dementia caused by multiple strokes, Huntington's disease, brain tumors, epilepsy, multiple sclerosis, or long-lasting brain problems caused by a serious head injury, among other similar conditions.
- You have been diagnosed with major depression or bipolar disorder at any point in the past year, or have ever been diagnosed with schizophrenia, as defined by standard medical diagnostic guidelines.
- You have had a serious problem with drug or alcohol misuse within the past year.
- You have a significant ongoing physical illness or an unstable health condition (such as a severe autoimmune disease or a history of cancer) that may make it hard to follow the study's requirements.
- You have significant difficulties with hearing, vision, or thinking and memory that would make it hard to take part in interviews in a meaningful way.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 512 67783307
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective sleep indicators and clinical sleep-related scales
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.